Cognitive pharmaceutical services in emerging health care systems - New patient medication management and concordance services in community pharmacy

Journal of Social and Administrative Pharmacy

Volumn 20, Issue 1, 2003, Pages 2-12

  Benrimoj, S I ^a   Peacocke, G ^a   Whitehead, P ^a   Kopecny, E ^a   Ward, P R ^a   Emerson, L ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Pharmacy Guild of Australia   (Australia)

Author keywords

Concordance; Medication cost; Medicine management

Indexed keywords

ARTICLE; AUSTRALIA; CONTROLLED STUDY; DRUG COST; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HUMAN; NORMAL HUMAN; PATIENT CARE; PATIENT COMPLIANCE; PHARMACIST; PHARMACY; SYMPTOM;

EID: 0037226516     PISSN: 02810662     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
2. The Pharmaceutical Society of Australia. Guidelines for Comprehensive Medication Review in Aged Care Facilities.
3. The Society of Hospital Pharmacists of Australia. Standards of Practice for Clinical Pharmacy 1996.
4. Ford S, Jones K. Integrating pharmacy fully into the primary care team. BMJ 1995;310:1620-21.
5. Erwin J, Britten N, Jones R. General practitioners' views on over the counter sales by community pharmacists. BMJ 1996;312:617-8.
6. Leape LL, Cullen DJ, Clapp MD. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-90.
7. Grymonpre RE, Williamson DA, Huynh DH, Desilets LM. A community-based pharmaceutical care model for the elderly: report on a pilot project. Int J Pharm Pract 1994;2:229-34.
8. Dorevitch A, Aronzon R, Zilberman L. Medication maintenance of chronic schizophrenic outpatients by a psychiatric clinical pharmacist: 10-year follow-up study. J Clin Pharm Ther 1993;18:183-6.
9. Swan GT, Benzie JL, Jones AN, Serjeant CS. Medication chart review: an analysis. Aust J Hosp Pharm 1984;14(3):105-8.
10. Coper L, Jessop J. Improving medication outcomes: intervention by community pharmacists through medication use reviews. Australian Pharmacist 1993;12(8):521-7.
11. Wright DJ, Purvis JR, Aykroyd RG, Chrystyn H. Clinical pharmacy services to residential and nursing homes: potential benefits of medication review. Pharm J 1994;253:8.
12. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc 1996;NS36:443-51.
13. Shibley MCH, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother 1997;31:713-9.
14. Cody M, McCombs JS, Parker JP. The Kaiser Permanente/USC Patient Consultation Study: change in quality of life. University of Southern California. Am J Health Syst Pharm 1998;55:2485-99.
15. Maguire T, McElnay JC. Therapeutic drug monitoring in community pharmacy - a feasibility study. Int J Pharm Pract 1993;2:168-71.
16. Gattis WA, Hasselbald V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Arch Intern Med 1999;159:1939-45.
17. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Am J Health Syst Pharm 1998;55:638-41.
18. Konzem SL, Gray DR, Kashyap ML. Effect of pharmaceutical care on optimum colestipol treatment in elderly hypercholesterolemic veterans. Pharmacotherapy 1997;17:576-83.
19. Benrimoj SI, Berry G, Collins D, Lauchlan R, Stewart K. A randomised trial on the effect of education and a professional allowance on clinical intervention rates in pharmacy: clinical and cost evaluation. Faculty of Pharmacy, University of Sydney. 1997.
20. Benrimoj SI, Langford JH, Berry G, Collins D, Lauchlan R, Stewart K et al. Economic impact of increased clinical intervention rates in community pharmacy. Pharmacoeconomics 2000;18(5):459-68.
21. Benrimoj SI, Emerson L, Whitehead P. The value of professional pharmacy services. A compilation of national and international literature encompassing research published between 1990 and 1998. The Pharmacy Guild of Australia, 1998.
22. Chen T, Casson C, Krass I, Benrimoj S. Medication regimen review process a guide for community pharmacists. Australian Pharmacist 1996;15(11):681-6.
23. Thomas, J. (Ed). Australian Prescription Products Guide. Australian Pharmaceutical Publishing Company Ltd, 1999.
24. Tatro, DS. (Ed). Drug Interaction Facts. Facts and Comparisons, 1992 (Third Edition).
25. Micromedex Healthcare Series. Thomson Micromedex, 1999.
26. The Canadian National Association of Pharmacy Regulatory Authorities: National Standards of Practice for Schedule II and Schedule III Drugs. 1995.
27. The New Zealand Ministry for Health: Draft statement of expectations of the pharmacist in the sale of OTC medicines. 1995.
28. The Pharmaceutical Society of Australia: Standards for the Provision of Pharmacist Only and Pharmacy Medicines in Community Pharmacy. 1999.
29. The Pharmaceutical Society of Australia: Professional Practice Standards. 1999.